HK shares ETFs Daily Report: Robotics and AI Lead HK ETFs! Hang Seng Biotech ETFs Plunge Over 3.7%, Biomedicine and Blockchain ETFs Collapse - 20260831
NewTimeSpace News: On August 31, 2026, the HK shares ETFs market showed modest gains in robotics and AI, Chinese technology and high-dividend segments, while biomedicine, blockchain, gold miner and fintech products corrected sharply across the board, with market divergence extremely pronounced.
Robotics and AI and Chinese technology themes proved relatively resilient. Global X China Robotics And Ai Etf (2807.HK) rose 2.39%, the top gainer, tracking the FactSet China Robotics and Artificial Intelligence Index (Net Total Return) and managed by Mirae Asset Global Investments (Hong Kong); Global X China Little Giant ETF (2815.HK) rose 1.62%; CSOP STAR 50 Index ETF (3109.HK) rose 1.48%; Ping An of China CSI HK Dividend ETF (3070.HK) rose 1.46%; Csop Ftse Vietnam 30 Etf (3004.HK) rose 1.12%; Bosera STAR 50 Index ETF (2832.HK) rose 0.98%; Global X China Cloud Computing ETF (2826.HK) rose 0.91%; Global X China Life Franklin Hk-Us Equity Select Etf (3428.HK) rose 0.79%; CSOP SZSE CHINEXT ETF (3147.HK) rose 0.50%; Csop Ftse Hk-Korea Tech+ Index Etf (3431.HK) rose 0.48%. Overall, robotics and AI, Chinese technology and high-dividend directions gained modestly, but all gains stayed within 2.5%, reflecting limited upside appetite.
HK shares ETFs Top 10 Gainers |
|||||
|
No. |
Code |
Name |
Change (%) |
Tracking Index |
Manager |
|
1 |
2807.HK |
Global X China Robotics And Ai Etf |
2.39 |
FactSet China Robotics and Artificial Intelligence Index (Net Total Return) |
Mirae Asset Global Investments (Hong Kong) |
|
2 |
2815.HK |
Global X China Little Giant ETF |
1.62 |
Solactive China Little Giant Index (Net Total Return) |
Mirae Asset Global Investments (Hong Kong) |
|
3 |
3109.HK |
CSOP STAR 50 Index ETF |
1.48 |
SSE STAR 50 Index |
CSOP Asset Management Limited |
|
4 |
3070.HK |
Ping An of China CSI HK Dividend ETF |
1.46 |
CSI Hong Kong Dividend Index |
Ping An Asset Management (Hong Kong) Limited |
|
5 |
3004.HK |
Csop Ftse Vietnam 30 Etf |
1.12 |
FTSE Vietnam 30 Price Index |
CSOP Asset Management Limited |
|
6 |
2832.HK |
Bosera STAR 50 Index ETF |
0.98 |
SSE STAR 50 Index |
Bosera Asset Management (International) |
|
7 |
2826.HK |
Global X China Cloud Computing ETF |
0.91 |
Solactive China Cloud Computing Index (Net Total Return) |
Mirae Asset Global Investments (Hong Kong) |
|
8 |
3428.HK |
Global X China Life Franklin Hk-Us Equity Select Etf |
0.79 |
CSI Select Market Moderate Index |
Mirae Asset Global Investments (Hong Kong) |
|
9 |
3147.HK |
CSOP SZSE CHINEXT ETF |
0.50 |
ChiNext Index |
CSOP Asset Management Limited |
|
10 |
3431.HK |
Csop Ftse Hk-Korea Tech+ Index Etf |
0.48 |
-- |
CSOP Asset Management Limited |
|
Source/Compiled by: Wind / NewTimeSpace, as of the close onAugust 31, 2026 Statistical note: Only HKD-denominated equity ETFs traded in the Hong Kong market are counted. |
|||||
On the downside, biomedicine and blockchain segments suffered concentrated sell-offs, with multiple ETFs down more than 3%. CSOP Hang Seng Biotech ETF (3174.HK) fell 3.73%, the largest drop; Chinaamc Hang Seng Hong Kong Biotech Index ETF (3069.HK) fell 3.69%; E Fund(Hk)Solactive Biopharma Select Index Etf (3186.HK) fell 3.61%; Pando Blockchain ETF (3112.HK) fell 3.61%; E Fund (HK) Solactive Global Gold Miner Select Index ETF (2824.HK) fell 3.54%; Global X Innovative Finance ETF (3185.HK) fell 3.42%; Samsung Blockchain Technologies Etf (3171.HK) fell 3.21%; Global X China Biotech ETF (2820.HK) fell 2.96%; E Fund (Hk) Wind Digital Technology Index Etf (3434.HK) fell 2.49%; Global X China Electric Vehicle Etf (2845.HK) fell 2.01%. Biomedicine, blockchain, gold miner and fintech products faced concentrated selling pressure, with all top-10 decliners down more than 2%; biomedicine and blockchain suffered the heaviest losses.
HK shares ETFs Top 10 Decliners |
|||||
|
No. |
Code |
Name |
Change (%) |
Tracking Index |
Manager |
|
1 |
3174.HK |
CSOP Hang Seng Biotech ETF |
-3.73 |
Hang Seng Hong Kong-Listed Biotech Index |
CSOP Asset Management Limited |
|
2 |
3069.HK |
Chinaamc Hang Seng Hong Kong Biotech Index ETF |
-3.69 |
Hang Seng Hong Kong-Listed Biotech Index |
China Asset Management (Hong Kong) |
|
3 |
3186.HK |
E Fund(Hk)Solactive Biopharma Select Index Etf |
-3.61 |
-- |
E Fund Asset Management (Hong Kong) Limited |
|
4 |
3112.HK |
Pando Blockchain ETF |
-3.61 |
-- |
Pando Limited |
|
5 |
2824.HK |
E Fund (HK) Solactive Global Gold Miner Select Index ETF |
-3.54 |
-- |
E Fund Asset Management (Hong Kong) Limited |
|
6 |
3185.HK |
Global X Innovative Finance ETF |
-3.42 |
-- |
Mirae Asset Global Investments (Hong Kong) |
|
7 |
3171.HK |
Samsung Blockchain Technologies Etf |
-3.21 |
-- |
Samsung Asset Management (Hong Kong) Limited |
|
8 |
2820.HK |
Global X China Biotech ETF |
-2.96 |
Solactive China Biotech Index (Net Total Return) |
Mirae Asset Global Investments (Hong Kong) |
|
9 |
3434.HK |
E Fund (Hk) Wind Digital Technology Index Etf |
-2.49 |
Wind Digital Technology Net Total Return Index (HKD) |
E Fund Asset Management (Hong Kong) Limited |
|
10 |
2845.HK |
Global X China Electric Vehicle Etf |
-2.01 |
Solactive China Electric Vehicle and Battery Index (Net Return) |
Mirae Asset Global Investments (Hong Kong) |
|
Source/Compiled by: Wind / NewTimeSpace, as of the close onAugust 31, 2026 Statistical note: Only HKD-denominated equity ETFs traded in the Hong Kong market are counted. |
|||||
NewTimeSpace Research data showed that on August 31, 2026, the HK shares ETFs market exhibited extreme divergence, with Chinese technology holding up modestly while biomedicine and blockchain retreated across the board. Global X China Robotics And Ai Etf, Global X China Little Giant ETF and STAR 50 products gained modestly and led the gains but by limited margins, while biomedicine, blockchain, gold miner and fintech products suffered concentrated sell-offs. Market hotspots rotated quickly from the previous session's fintech and Taiwan defensive names to robotics and AI and Chinese technology, but the overall profit effect was weak, with selling pressure especially pronounced in biomedicine and blockchain, leaving market sentiment cautious.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- HK shares ETFs Daily Report: Fintech Leads Again! Taiwan and Gold Miners Advance in Tandem as Leveraged ChiNext and STAR 50 Retreat Under Pressure - 20260828
- HK shares ETFs Daily Report: China Little Giant Jumps Near 5%! Semiconductors and STAR 50 Counterattack Broadly as Clean Energy and High-Dividend Stocks Come Under Pressure - 20260827
- HK shares ETFs Daily Report: Fintech Leads HK Shares! Taiwan, Blockchain and STAR 50 Rebound Across the Board, Central-SOE Dividends and Vietnam Under Mild Pressure - 20260826
- HK shares ETFs Daily Report: Biomedicine Rebounds Across the Board! Gold Miners and Leveraged ChiNext Under Pressure and Pull Back - 20260825
- HK shares ETFs Daily Report: Vietnam and K-Pop Strengthen Against the Tide! Leveraged ChiNext Plunges Nearly 8%, China Tech Collapses Across the Board - 20260824
